Research Progress Concerning Dual Blockade of Lymphocyte-Activation Gene 3 and Programmed Death-1/Programmed Death-1 Ligand-1 Blockade in Cancer Immunotherapy: Preclinical and Clin...

por Qi, Yihang, Chen, Li, Liu, Qiang, Kong, Xiangyi, Fang, Yi, Wang, Jing
Publicado 2021

PD-1/PD-L1 Inhibitor-Associated Myocarditis: Epidemiology, Characteristics, Diagnosis, Treatment, and Potential Mechanism

por Dong, Hao, Qi, Yihang, Kong, Xiangyi, Wang, Zhongzhao, Fang, Yi, Wang, Jing
Publicado 2022

Expression signatures and roles of microRNAs in inflammatory breast cancer

por Qi, Yihang, Wang, Xiangyu, Kong, Xiangyi, Zhai, Jie, Fang, Yi, Guan, Xiaoxiang, Wang, Jing
Publicado 2019

Efficacy and Safety of Anti-PD-1/ PD-L1 Monotherapy for Metastatic Breast Cancer: Clinical Evidence

por Qi, Yihang, Zhang, Lin, Wang, Zhongzhao, Kong, Xiangyi, Zhai, Jie, Fang, Yi, Wang, Jing
Publicado 2021

Molecular and Clinical Characterization of LAG3 in Breast Cancer Through 2994 Samples

por Liu, Qiang, Qi, Yihang, Zhai, Jie, Kong, Xiangyi, Wang, Xiangyu, Wang, Zhongzhao, Fang, Yi, Wang, Jing
Publicado 2021

Primary Giant Cell Tumor of the Breast With Pulmonary Metastasis: A Case Report and Review of the Literature

por Zhang, Wenxiang, Kong, Xiangyi, Qi, Yihang, Wang, Xiangyu, Liu, Qiang, Fang, Yi, Song, Yan, Wang, Jing
Publicado 2021

Molecular and Clinical Characterization of CCT2 Expression and Prognosis via Large-Scale Transcriptome Profile of Breast Cancer

por Liu, Qiang, Qi, Yihang, Kong, Xiangyi, Wang, Xiangyu, Zhang, Wenxiang, Zhai, Jie, Yang, Yazhe, Fang, Yi, Wang, Jing
Publicado 2021

Efficacy and safety of PD-1 and PD-L1 inhibitors combined with chemotherapy in randomized clinical trials among triple-negative breast cancer

por Qi, Yihang, Zhang, Wenxiang, Jiang, Ray, Xu, Olivia, Kong, Xiangyi, Zhang, Lin, Fang, Yi, Wang, Jingping, Wang, Jing
Publicado 2022

Nutritional Risk Index Predicts Survival in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy

por Chen, Li, Qi, Yihang, Kong, Xiangyi, Su, Zhaohui, Wang, Zhongzhao, Wang, Xiangyu, Du, Yaying, Fang, Yi, Li, Xingrui, Wang, Jing
Publicado 2022

LINC01355 suppresses breast cancer growth through FOXO3-mediated transcriptional repression of CCND1

por Ai, Bolun, Kong, Xiangyi, Wang, Xiangyu, Zhang, Kai, Yang, Xue, Zhai, Jie, Gao, Ran, Qi, Yihang, Wang, Jing, Wang, Zhongzhao, Fang, Yi
Publicado 2019

Mechanism of trastuzumab resistance caused by HER-2 mutation in breast carcinomas

por Kong, Xiangyi, Zhang, Kai, Wang, Xiangyu, Yang, Xue, Li, Yalun, Zhai, Jie, Xing, Zeyu, Qi, Yihang, Gao, Ran, Feng, Xiaoli, Wang, Jing, Fang, Yi
Publicado 2019

Epidemiological and clinical characteristics of cancer patients with COVID-19: A systematic review and meta-analysis of global data

por Kong, Xiangyi, Qi, Yihang, Huang, Junjie, Zhao, Yang, Zhan, Yongle, Qin, Xuzhen, Qi, Zhihong, Atanda, Adejare (Jay), Zhang, Lei, Wang, Jing, Fang, Yi, Jia, Peng, Golozar, Asieh, Zhang, Lin, Jiang, Yu
Publicado 2021